News for Anixa Biosciences, Inc. (ANIX)

PR NewswireSAN JOSE, Calif., March 25, 2025 VERDI's personalized vaccines have demonstrated safety and efficacy in cancer patientsSAN JOSE, Calif., March 2

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

PR NewswireSAN JOSE, Calif., March 17, 2025 SAN JOSE, Calif., March 17, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: AN

PR NewswireSAN JOSE, Calif., March 10, 2025 SAN JOSE, Calif., March 10, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: AN

PR NewswireSAN JOSE, Calif., Feb. 26, 2025 SAN JOSE, Calif., Feb. 26, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX

PR NewswireSAN JOSE, Calif., Feb. 25, 2025 SAN JOSE, Calif., Feb. 25, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX

PR NewswireSAN JOSE, Calif., Feb. 24, 2025 SAN JOSE, Calif., Feb. 24, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX

PR NewswireSAN JOSE, Calif., Feb. 18, 2025 Amendment expands the potential benefits of CAR-T therapy allowing a second dose and includes more ovarian cance

PR NewswireSAN JOSE, Calif., Jan. 21, 2025 SAN JOSE, Calif., Jan. 21, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX

On January 17, 2025, Titterton Lewis H Jr, a Director at Anixa Biosciences Inc, purchased 10,000 shares of the company. Following this transaction, the insider

Anixa biosciences director Lewis Titterton buys shares worth $25,700

On January 15, 2025, Michael Catelani, President, Chief Operating Officer, and Chief Financial Officer of Anixa Biosciences Inc (ANIX), purchased 9,289 shares o

Anixa Biosciences president Michael Catelani buys $19,971 in shares

ANIX's focus on breast and ovarian cancer immunotherapies shows promise but lacks substantial data, with ongoing trials in early phases and limited results so far.

PR NewswireSAN JOSE, Calif, Dec. 4, 2024 SAN JOSE, Calif, Dec. 4, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a

PR NewswireSAN JOSE, Calif., Nov. 22, 2024 SAN JOSE, Calif., Nov. 22, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX

Anixa Biosciences diversifies with Bitcoin investment

PR NewswireSAN JOSE, Calif., Nov. 18, 2024 Third cohort dose is one million CAR positive cells; ten times higher than the first cohort dose SAN JOSE, Calif

The Dow Jones index closed higher by over 650 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the compa...